A Vaccine To Prevent Breast Cancer Recalibrates The Possible
Outsourced Pharma
Outsourcing Everything Is The Biotech Blueprint
Outsourced Pharma
Patient who received breast cancer vaccine as part of clinical trial speaks about experience
WPTV West Palm Beach
Moffitt Continues Studying CAR T To Treat Ovarian Cancer
Moffitt Cancer Center | Endeavor
Why Anixa Biosciences’ Phase 2 breast cancer vaccine push matters more than the manufacturing deal itself
PharmaDeviceNews
Latest News & Events
Anixa Biosciences Expands Global Patent Portfolio with Australian Patent Acceptance for Breast Cancer Vaccine Technology
Read More...Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
Read More...Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Read More...